Editorial Board About Us

Alan W Partin

All articles from this author are listed below.

Volume 7, Number 4 Literature Reviews

Prostate Cancer

Reviewing the Literature

Stephen J Freedland Alan W Partin

Volume 7, Number 3 Literature Reviews

Prostate Cancer

Reviewing the Literature

Stephen J Freedland Alan W Partin

Volume 7, Number 2 Literature Reviews

Prostate Cancer

Stephen J Freedland Alan W Partin

Volume 7, Number 1 Point-Counterpoint

Optimal Surgical Management of the Obese Man With Prostate Cancer: Laproscopic or Perineal Radical Prostatectomy

Stephen J Freedland Alan W Partin

Volume 7, Number 1 Meeting Reviews

Prostate Cancer Update: 2004

Stephen J Freedland Alan W Partin

Prostate cancer Chemotherapy High-intensity focused ultrasound Docetaxel Finasteride Dutasteride

Volume 8, Number 4 Literature Reviews

Prostate Cancer

Reviewing the Literature

Danil V Makarov Alan W Partin

Volume 8, Number 3 Review Articles

The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer

Diagnostic Review

Mohamad E Allaf Alan W Partin H Ballentine Carter

Despite advances in noninvasive staging, pelvic lymph node dissection (PLND) remains the most accurate means of detecting lymph node metastases in men with clinically localized prostate cancer. Nomograms exist that can identify patients at low risk for lymphatic metastases according to preoperative information. In general, it seems reasonable to omit PLND in men with a biopsy Gleason sum of 6 or less and a prostate-specific antigen level of 10 ng/mL or less. Ultimately, however, this decision should be made according to physician and patient preference, considering the low contemporary morbidity associated with PLND. When PLND is performed, studies suggest that an extended dissection maximizes the detection rate of nodal involvement. Retrospective data indicate that an extended dissection might play a therapeutic role in a subset of patients with a limited lymph node burden. However, this might be an artifact of stage migration, and prospective studies are needed to evaluate this further. [Rev Urol. 2006;8(3):112-119]

Prostate cancer Nomograms Radioimmunoscintigraphy Lymphadenectomy Clinical staging Magnetic resonanceimaging Algorithms

Volume 8, Number 3 Meeting Reviews

Best of the 2006 AUA Annual Meeting

Meeting Review

Tobias Klatte Michael K Brawer Arie S Belldegrun John P Stein John P Mulhall Claus G Roehrborn Michael E Aldridge Li-Ming Su Shachi Tyagi Danil V Makarov Ellen Shapiro Alan W Partin Michael B Chancellor Victor W Nitti J Curtis Nickel Jacob Rajfer

Highlights from the 2006 Annual Meeting of the American Urological Association May 20–25, 2006 Atlanta, GA

Prostate cancer Infertility Benign prostatic hyperplasia Bladder cancer Kidney cancer Lower urinary tract symptoms Bladder exstrophy Overactive bladder Interstitial cystitis Stress urinary incontinence Peyronie’s disease Spina bifida Neurogenic bladder Erectile dysfunction Chronic pelvic pain syndrome Chronic prostatitis Tumor markers Androgen replacement therapy Ejaculatory dysfunction Anorectal malformations Renal stones Robotic-assisted radical prostatectomy

Volume 8, Number 2 Literature Reviews

Prostate Cancer

Reviewing the Literature

Alan W Partin Danil V Makarov